Las Vegas, NV -- (SBWIRE) -- 09/21/2013 -- PennyStockEarnings Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is On: Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX), GTx, Inc. (NASDAQ:GTXI), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Life Technologies Corp. (NASDAQ:LIFE)
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) slipped -0.03% and closed at $124.49 in the last trading session with the overall traded volume of 2.52 million shares, less versus the average volume of 3.51 million shares. Its 52 weeks high price was $136.87 and suffered lowest price of $68.12 in the same period.
It has market cap of $9.13 billion while its total outstanding shares are 73.34 million. Its stock’s 3 months performance stands at +49.96%. Onyx Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies that target the molecular mechanisms that cause cancer in the United States and internationally.
Has ONXX Found The Bottom and Ready To Move Up? Find Out Here
GTx, Inc. (NASDAQ:GTXI) declined -4.93% with the closing price of $2.12. The overall volume in the last trading session was 2.43 million shares. Its fifty two week range was $1.31-$7.24. The total market capitalization remained $133.95 million.
The stock fell -48.92% in this year and reported the gain of +12.77% in the last 5 days. In its share capital, the company has 63.19 million outstanding shares. GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecules for the treatment of cancer, cancer supportive care, and other serious medical conditions.
Why Should Investors Buy GTXI After the Recent Fall? Just Go Here and Find Out
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) increased +0.77% to close at $37.72 in the last trading session and its total traded volume was 2.43 million shares, beating the average volume of 3.36 million. The company has market cap of $31.87 billion.
The stock has positive year-to-date performance of +1.40% while its quarterly performance remained -2.98%. Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes pharmaceutical products worldwide.
Will TEVA Continue To Move Higher? Find Out Here
Life Technologies Corp. (NASDAQ:LIFE) surged +0.05% to closed at $74.91 and its overall volume in the last trading session was 2.52 million shares, beating the average volume of 1.97 million. It has market cap of $12.93 billion while its total outstanding shares are 172.66 million.
The stock gained +54.71% in this year and reported the increase of +0.23% in the last 5 days. Its 3 months performance stands at +1.23%. Life Technologies Corporation operates as a life sciences company. The company’s Research Consumables business group offers molecular and cell biology reagents, endpoint PCR, and other benchtop instruments and consumables.
For How Long LIFE’s Gloss will Attract Investors? Find out via this report
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)